Short answer
LEMAITRE VASCULAR INC (LMAT) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Filing contains only forward-looking-statement cautionary language.
LEMAITRE VASCULAR INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only forward-looking-statement cautionary language
- Investors should rely on historical results and risk disclosures rather than projections in this excerpt
- No operating results, financial metrics, or guidance included in the provided text
Item EX-99.1 · Exhibit EX-99.1
- Q1 sales $66.6M, up 11% with 10% organic growth, signaling broad-based demand acceleration
- Gross margin reached 72.7%, up 350 bps, while operating income rose 41% to $17.8M
- EPS increased 42% to $0.68; cash and marketable securities totaled $367.2M, supporting capital returns
- 2026 guidance raised or reaffirmed at $280M midpoint sales and $3.00 midpoint EPS, implying 12% and 19% growth
- Quarterly dividend increased to $0.25/share; separate $100M repurchase authorization runs through February 18, 2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LEMAITRE VASCULAR INC 8-K filings
Get the next LMAT 8-K as it lands
Follow LMAT for push alerts, or ask the research agent what this filing means.